Published in Cancer Weekly, June 27th, 2000
Using a laboratory-developed analog of somatostatin, a hypothalamic hormone that inhibits the release of growth hormone, researchers were able to target specific receptors on tumor sites and reverse cancer growth. This potent compound could be the "magic bullet" in the fight against a cancer particularly resistant to therapy.
"This analog is super potent. The targeted chemotherapy inhibited the tumors beautifully," said research leader Andrew V. Schally, a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.